Treatment of High-Risk Biochemically Recurrent Prostate Cancer with Enzalutamide in Combination with Leuprolide: Secondary End Points from the EMBARK Trial: Erratum
Year: 2026
Type: erratum
Source: The Journal of Urology
Authors: Neal D. Shore, Martin Gleave, Ugo De Giorgi, Antti Rannikko, Christopher M. Pieczonka, Swetha Sridharan, Klaus Brasso, Henry H. Woo, Antonio Gómez Caamaño, Jeff W. Saranchuk, Luke T. Nordquist, Ubirajara Ferreira, Yiyun Tang, Brad Rosbrook, Gabriel P. Haas, Matt Rosales, Fabian Zohren, Jamal Tarazi, Stephen J. Freedland
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: closed
OpenAlex ID: W7167841812